Article Information
History
- October 4, 2019.
Article Versions
- Version 1 (September 18, 2019 - 04:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ryan von Kleeck1,3,
- Sonja A. Brankovic*,1,3,
- Ian Roberts1,2,
- Elizabeth A. Hawthorne1,
- Kyle Bruun1,
- Paola Castagnino1,2 and
- Richard K. Assoian1,2,3,#
- 1Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia PA 19104
- 2Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia PA 19104
- 3Center for Engineering MechanoBiology, University of Pennsylvania, Philadelphia PA 19104
- *G.W. Woodruff School of Mechanical Engineering, Georgia Tech, Atlanta GA 30313
- ↵#Address editorial correspondence to: Richard K. Assoian, email: assoian{at}pennmedicine.upenn.edu, Tel: 215-898-7157
Posted October 04, 2019.
Premature arterial stiffening in Hutchinson-Gilford Progeria Syndrome linked to early induction of Lysyl Oxidase (LOX) and corrected by LOX inhibition
